Bluebird bio Inc (BLUE) — Long-term Investment Intensity
Bluebird bio Inc (BLUE) has a Long-term Investment Intensity of 0.3% as of December 2022. Long-term investments of $1.41 Million represent 0.3% of total assets of $554.90 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Bluebird bio Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Bluebird bio Inc Long-term Investment Intensity (2014–2022)
This chart shows how Bluebird bio Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2014 to 2022. As of December 2022, the intensity stands at 0.3%, reflecting long-term investments of $1.41 Million against total assets of $554.90 Million USD. For the complete balance sheet picture, see balance sheet size of Bluebird bio Inc.
Annual Long-term Investment Intensity for Bluebird bio Inc (2014–2022)
The table below presents the year-by-year Long-term Investment Intensity for Bluebird bio Inc from 2014 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BLUE current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.3% | $1.41 Million | $554.90 Million | ▼ -16.1 pp |
| 2021 | 16.4% | $97.11 Million | $593.79 Million | ▲ +9.5 pp |
| 2020 | 6.9% | $122.89 Million | $1.78 Billion | ▼ -0.7 pp |
| 2019 | 7.6% | $131.51 Million | $1.73 Billion | ▼ -15.0 pp |
| 2018 | 22.6% | $506.12 Million | $2.24 Billion | ▲ +5.5 pp |
| 2017 | 17.1% | $324.19 Million | $1.90 Billion | ▲ +0.9 pp |
| 2016 | 16.1% | $180.45 Million | $1.12 Billion | ▼ -18.6 pp |
| 2015 | 34.7% | $347.81 Million | $1.00 Billion | ▲ +31.4 pp |
| 2014 | 3.3% | $18.45 Million | $556.74 Million | — |